News in the Life Sciences Industry

STOCKHOLM, May 14, 2020 /PRNewswire/ -- "In the end of the first quarter of 2020 much of the activity at the company was focused on assessing and mitigating any potential impact Covid-19 might have on NefIgArd and I am happy to report that, due to the fact that the Part A of the study was fully... Read more ››

MONTPELLIER, France, May 14, 2020 /PRNewswire/ -- The French company IDvet has launched a new serological test to detect antibodies against COVID-19 with a specificity of 99.9%, significantly lowering the rate of false positive results.

STOCKHOLM, May 14, 2020 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR) and Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden, have had a multi-year research collaboration in the CNS field, and their joint doctoral student Hlin Kvartsberg's solid work has now been... Read more ››

LUND, Sweden, May 13, 2020 /PRNewswire/ -- Immunovia AB (publ) ("Immunovia") today provides an update on the actions that the company is taking in response to the coronavirus (COVID-19) pandemic. During these challenging times, Immunovia remains focused on the sales start of the first-to-market... Read more ››

STOCKHOLM, May 13, 2020 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announces that two abstracts with data in multiple myeloma have been accepted by the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting. One of the abstracts relates to the pivotal phase 2 HORIZON... Read more ››

STOCKHOLM, May 13, 2020 /PRNewswire/ -- Sprint Bioscience today announces that after a series of preclinical research advances in the VADA project, it has been decided to publish the project's target protein. The goal is to develop drug substances that inhibit the protein vaccinia-related... Read more ››

STOCKHOLM, May 13, 2020 /PRNewswire/ -- The positive trend from the end of 2019 continues as OssDsign kicks off 2020 with continued consecutive sales growth of 52% in Q1 vs Q4 2019.

LUND, Sweden, May 13, 2020 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company's management team will participate in the following upcoming investor conferences:

STOCKHOLM, May 13, 2020 /PRNewswire/ -- Cereno Scientific today announced that the company has expanded its global footprint by establishing a subsidiary with new office space located in Kendall Square at the Cambridge Innovation Center (CIC), Cambridge, Boston, Massachusetts. The CIC is... Read more ››

LUND, Sweden, May 12, 2020 /PRNewswire/ -- Immunovia invites you to a teleconference (in English) for all stakeholders and media on Wednesday, May 13, 2020 at 16:30 CET. Mats Grahn, CEO will present an update on the company's COVID-19 response as well as an update on the activities in preparation... Read more ››

STOCKHOLM, May 12, 2020 /PRNewswire/ -- Polygiene Technology in Dictation Solutions from Olympus professional audio. Healthcare, Legal, Business and Law Enforcement Personnel Can Reduce Exposure to Microbes During Dictation.

STOCKHOLM, May 12, 2020 /PRNewswire/ -- Q-linea AB (publ) (OMX: QLINEA), today announced positive results from a prospective patient study conducted together with Uppsala University Hospital. In the study, the ASTar system analyzed samples from 17 patients and the antibiotic panel consisted... Read more ››

STOCKHOLM, May 12, 2020 /PRNewswire/ -- FINANCING AGREEMENT OF UP TO SEK 216 MILLION